OpenInsiders01Web Canada
SEC INSIDER TRANSACTIONS

VEEVA SYSTEMS INC (VEEV) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

VEEV · VEEVA SYSTEMS INC

How to read this data ↗
More transaction filters

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters
Stale snapshot · Covered: filings 2026-10-15 to 2026-11-13 · 2 filings · fetched 2026-11-13T20:38:29Z

View six-calendar-month insider history →

Recent reported activity

0purchase rows on this page
3sale rows on this page
5matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filedReporting owner(s)Code / securityQuantityPrice as filedOwnershipSource
2026-10-15Filed 2026-10-19Ritter GordonDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Pro rata distribution from Emergence Capital Partners II, L.P. ("Emergence) in accordance with the exemption under Rule 16a-9(a) and Rule 16a-13 of the Securities Exchange Act of 1934, as amended.

F2 Shares held by The Ritter-Metzler Revocable Trust dated November 6, 2000 (the "Trust"). The Reporting Person is a trustee and beneficiary of the Trust and may be deemed to share voting and dispositive power with regard to the reported shares held by the Trust. The Reporting Person disclaims beneficial ownership of the reported shares held by the Trust, except to the extent, if any, of his pecuniary interest therein.

F3 The Reporting Person is voluntarily making this filing to report certain exempt transactions. On October 15, 2026, Emergence distributed in-kind, without consideration, 250,000 shares of Class A Common Stock pro-rata to its partners in accordance with the exemption under Rule 16a-9(a) and Rule 16a-13 of the Securities Exchange Act of 1934, as amended.

F4 The sole general partner of Emergence is Emergence Equity Partners II, L.P. ("EEP II"), and the sole general partner of EEP II is Emergence GP Partners, LLC ("EGP", and together with Emergence and EEP II, the "Emergence Entities"), and each of EEP II and EGP may be deemed to have sole voting and dispositive power with respect to the shares held by Emergence, and EGP may be deemed to have sole voting and dispositive power with respect to the shares held by EEP II. The Reporting Person is a partner of EEP II and a member of EGP and serves on the Issuer's board of directors. The Reporting Person disclaims beneficial ownership of the reported shares held by the Emergence Entities except to the extent of his pecuniary interest therein, if any, by virtue of the limited liability company interest he owns in EGP and the partnership interest he owns in EEP II.

F5 Shares held by GABACOR Holdings LLC ("GABACOR"). The Reporting Person is a controlling person of GABACOR and may be deemed to share voting and dispositive power with regard to the reported shares held by GABACOR. The Reporting Person disclaims beneficial ownership of the reported shares held by GABACOR, except to the extent, if any, of his pecuniary interest therein.

References: F3, F4

J Other reported codeClass A Common Stock · Non-derivative250,000D0IndirectBy Emergence Capital Partners II, L.P.Form 4 ↗0001628280-26-066333
2026-10-15Filed 2026-10-19Ritter GordonDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Pro rata distribution from Emergence Capital Partners II, L.P. ("Emergence) in accordance with the exemption under Rule 16a-9(a) and Rule 16a-13 of the Securities Exchange Act of 1934, as amended.

F2 Shares held by The Ritter-Metzler Revocable Trust dated November 6, 2000 (the "Trust"). The Reporting Person is a trustee and beneficiary of the Trust and may be deemed to share voting and dispositive power with regard to the reported shares held by the Trust. The Reporting Person disclaims beneficial ownership of the reported shares held by the Trust, except to the extent, if any, of his pecuniary interest therein.

F3 The Reporting Person is voluntarily making this filing to report certain exempt transactions. On October 15, 2026, Emergence distributed in-kind, without consideration, 250,000 shares of Class A Common Stock pro-rata to its partners in accordance with the exemption under Rule 16a-9(a) and Rule 16a-13 of the Securities Exchange Act of 1934, as amended.

F4 The sole general partner of Emergence is Emergence Equity Partners II, L.P. ("EEP II"), and the sole general partner of EEP II is Emergence GP Partners, LLC ("EGP", and together with Emergence and EEP II, the "Emergence Entities"), and each of EEP II and EGP may be deemed to have sole voting and dispositive power with respect to the shares held by Emergence, and EGP may be deemed to have sole voting and dispositive power with respect to the shares held by EEP II. The Reporting Person is a partner of EEP II and a member of EGP and serves on the Issuer's board of directors. The Reporting Person disclaims beneficial ownership of the reported shares held by the Emergence Entities except to the extent of his pecuniary interest therein, if any, by virtue of the limited liability company interest he owns in EGP and the partnership interest he owns in EEP II.

F5 Shares held by GABACOR Holdings LLC ("GABACOR"). The Reporting Person is a controlling person of GABACOR and may be deemed to share voting and dispositive power with regard to the reported shares held by GABACOR. The Reporting Person disclaims beneficial ownership of the reported shares held by GABACOR, except to the extent, if any, of his pecuniary interest therein.

References: F1, F2

J Other reported codeClass A Common Stock · Non-derivative14,301A0IndirectBy the Ritter-Metzler Revocable Trust dated November 6, 2000Form 4 ↗0001628280-26-066333
2026-10-14Filed 2026-10-16Faddis JonathanOfficer · SVP, Gen. Counsel, Secretary
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 15, 2026.

F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $299.9700 to $300.1400 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $298.8250 to $299.7500 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $297.8200 to $298.6600 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

References: F1, F4

S Sale (market/private)Class A Common Stock · Non-derivative708D298.1925DirectForm 4 ↗0001628280-26-066134
2026-10-14Filed 2026-10-16Faddis JonathanOfficer · SVP, Gen. Counsel, Secretary
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 15, 2026.

F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $299.9700 to $300.1400 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $298.8250 to $299.7500 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $297.8200 to $298.6600 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

References: F1, F3

S Sale (market/private)Class A Common Stock · Non-derivative975D299.2928DirectForm 4 ↗0001628280-26-066134
2026-10-14Filed 2026-10-16Faddis JonathanOfficer · SVP, Gen. Counsel, Secretary
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 15, 2026.

F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $299.9700 to $300.1400 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $298.8250 to $299.7500 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $297.8200 to $298.6600 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

References: F1, F2

S Sale (market/private)Class A Common Stock · Non-derivative3,515D300.1393DirectForm 4 ↗0001628280-26-066134

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.